EichorEICHOR
Condition: Tgct Synced from ClinicalTrials.gov · August 04, 2026

Recruiting studies: Tgct

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)
Phase 2 · 3 location(s) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of M · NCT07499362
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Phase 1 · 18 location(s) · Xencor, Inc. · NCT06276491
Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumo
NA · 12 location(s) · Centre Leon Berard · NCT05588700
MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial
Phase N/A · 5 location(s) · University of Southern California · NCT06060873
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractor
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT02390752
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
Phase 1 · 17 location(s) · Abbisko Therapeutics Co, Ltd · NCT04192344
MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib
Phase N/A · 1 location(s) · Deciphera Pharmaceuticals, LLC · NCT07075471
Follow-up After Surgery for Testicular Cancer
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT05670938
A Prospective Study to Evaluate miRNA371 and Outcomes in Patients With Newly Diagnosed Germ Cell Tumors
Phase N/A · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07453082
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →